Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A special matrix of amino acid antigenic similarity for computer detection of the potential antigenic proximity of unrelated proteins is proposed. The matrix was built using the data concerning affinities of amino acid residue interactions between subunits in oligomeric proteins. The diagonal elements of the matrix characterize the recognition of amino acid residues and the non-diagonal ones represent the relative similarity measure of antibody--amino acid residue interactions specificity. The application of the new matrix for comparing proteins allows the hydrophilic potentially immunologically active regions of sequences to be picked out as similar fragments. When the
influenza
virus hemagglutinin was compared with 116 human proteins, eight fragments were picked out, that could not be determined by means of the routinely used MDM78 matrix. The antigenic similarity matrix for defining the forbidden structures is proposed to be used for preparing the peptidic antiviral vaccines.
Mol
Biol (Mosk)
PMID:[Amino acid similarity matrix for detecting the antigenically similar sequences in non-related proteins]. 246 Jul 35
The murine
influenza
virus resistance locus Mx consists of more than one interferon-responsive transcription unit. We isolated clones of the transcripts of a second Mx gene (Mx2) which is closely linked to the well-characterized resistance gene and determined their sequences. Mx2 mRNA is more than 90% identical to Mx1 mRNA in the region corresponding to the amino termini of the encoded proteins. Mx2 mRNAs of mouse strains BALB/c and CBA have open reading frames apparently interrupted by mutations. Interferon-treated cells from strain A2G and other
influenza
virus-resistant strains failed to express detectable amounts of Mx2 transcripts.
Mol
Cell Biol 1988 Oct
PMID:Identification of a second interferon-regulated murine Mx gene. 246 Jul 45
Cytotoxic T-cell recognition of an engineered variant of the
influenza
viral haemagglutinin (HA), expressed in vaccinia virus, was investigated. We show that the insertion of a Foot-and-Mouth Disease virus (FMDV) immunogenic peptide into the HA results in major disruption of its higher order structure with intracellular rather than cell surface localization accompanying the loss of conformational epitopes detected by antibody. In contradistinction to antibody, recognition of the chimaeric molecule by HA-specific class I-restricted cytotoxic T-cells was unimpaired, demonstrating that class I-specific T-cells recognize, in majority, continuous epitopes rather than conformational epitopes in the HA.
Mol
Immunol 1988 Dec
PMID:Class I MHC-restricted cytotoxic T cells efficiently recognize haemagglutinin that is defective in protein folding and cell surface expressions. 246 91
Some new analogues of ribonucleoside-5'-triphosphates modified in 3'-ribose position and base [CTP (3'NH2), CTP (3'NH2) (5Me), CTP (3'N3) (5 Me), RvTP (3'N3)] have been synthesized. The inhibitions of RNA-synthesis catalyzed by the
influenza
A viral RNA-polymerase in cell free system and by the RNA-polymerase II from mice liver in the system of cellular nuclei by these reagents have been compared. All the studied preparations efficiently inhibited the RNA-synthesis in both cases. The inhibitors modified only in 3'-ribose position did not express specificity to any of RNA-polymerases tested, while some analogues having two modification in the molecule demonstrated the selective inhibition of RNA-synthesis directed by the
influenza
A viral RNA-polymerase [ara GTP (3'NH2), RvTP (3'N3')].
Mol
Gen Mikrobiol Virusol 1989 Jan
PMID:[Inhibitory effect of various 3'-amino- and 3'-azido-3'-deoxyribonucleotide-5'-triphosphates on RNA synthesis, catalyzed by RNA polymerase of influenza type A virus and cellular RNA-polymerase]. 247 25
To find the role of any
influenza
virus gene in regulation of the RNA-segments replication the transfer of ts-mutants to nonpermissive temperature on the late step of infection has been used (shift-up). The mutants having impaired the NS or NP-genes have been obtained and studied. The transfer of mutants to partially nonpermissive conditions (when the amount of replication is decreased, but it still continues) results in the distinct return to the early mode of replication in ts-mutant with the mutation in NS-gene. This suggests the NS-gene role in replication of viral RNA-segments, in particular, in the switch from the "early" stage of replication to the "late" one. In NP-gene mutant only the decrease in general replication takes place without the shift to "early" replication mode.
Mol
Gen Mikrobiol Virusol 1988 Dec
PMID:[Role of the NS gene in regulating the synthesis of RNA-segments of the influenza A virus]. 247 27
We cloned and sequenced a 2.35-kilobase EcoRI fragment of genomic DNA from a local freshwater fish (Perca fluviatilis) that strongly hybridized to probes derived from the murine
influenza
virus resistance gene Mx. The cloned fish DNA contained blocks of sequences related to Mx gene exons 3 to 8, which appeared to represent exons of a bona fide fish gene because they were separated by intron sequences flanked by consensus splice acceptor and donor sites. Injection of double-stranded RNA into the peritoneal cavity of trouts resulted in 5- to 10-fold elevated levels of two liver mRNAs of about 2.0 to 2.5 kilobases in length that hybridized to the cloned genomic DNA. High sequence similarity between this fish gene and the murine Mx gene, identical exon lengths, and similar inducibilities in vivo by double-stranded RNA indicate that we isolated a fragment of a fish Mx gene.
Mol
Cell Biol 1989 Jul
PMID:A double-stranded RNA-inducible fish gene homologous to the murine influenza virus resistance gene Mx. 247 61
Human cells treated with interferon synthesize two proteins that exhibit high homology to murine Mx1 protein, which has previously been identified as the mediator of interferon-induced cellular resistance of mouse cells against
influenza
viruses. Using murine Mx1 cDNA as a hybridization probe, we have isolated cDNA clones originating from two distinct human Mx genes, designated MxA and MxB. In human fibroblasts, expression of MxA and MxB is strongly induced by alpha interferon (IFN-alpha), IFN-beta, Newcastle disease virus, and, to a much lesser extent, IFN-gamma, MxA and MxB proteins have molecular masses of 76 and 73 kilodaltons, respectively, and their sequences are 63% identical. A comparison of human and mouse Mx proteins revealed that human MxA and mouse Mx2 are the most closely related proteins, showing 77% sequence identity. Near their amino termini, human and mouse Mx proteins contain a block of 53 identical amino acids and additional regions of very high sequence similarity. These conserved sequences are also present in a double-stranded RNA-inducible fish gene, which suggests that they may constitute a functionally important domain of Mx proteins. In contrast to mouse Mx1 protein, which accumulates in the nuclei of IFN-treated mouse cells, the two human Mx proteins both accumulate in the cytoplasm of IFN-treated cells.
Mol
Cell Biol 1989 Nov
PMID:cDNA structures and regulation of two interferon-induced human Mx proteins. 248 Dec 29
The assembly of mammalian pre-mRNAs into large 50S to 60S complexes, or spliceosomes, containing small nuclear ribonucleoproteins (snRNPs) leads to the production of splicing intermediates, 5' exon and lariat-3' exon, and the subsequent production of spliced products.
Influenza
virus NS1 mRNA, which encodes a virus-specific protein, is spliced in infected cells to form another viral mRNA (the NS2 mRNA), such that the ratio of unspliced to spliced mRNA is 10 to 1. NS1 mRNA was not detectably spliced in vitro with nuclear extracts from uninfected HeLa cells. Surprisingly, despite the almost total absence of splicing intermediates in the in vitro reaction, NS1 mRNA very efficiently formed ATP-dependent 55S complexes. The formation of 55S complexes with NS1 mRNA was compared with that obtained with an adenovirus pre-mRNA (pKT1 transcript) by using partially purified splicing fractions that restricted the splicing of the pKT1 transcript to the production of splicing intermediates. At RNA precursor levels that were considerably below saturation, approximately 10-fold more of the input NS1 mRNA than of the input pKT1 transcript formed 55S complexes at all time points examined. The pKT1 55S complexes contained splicing intermediates, whereas the NS1 55S complexes contained only precursor NS1 mRNA. Biotin-avidin affinity chromatography showed that the 55S complexes formed with either NS1 mRNA or the pKT1 transcript contained the U1, U2, U4, U5, and U6 snRNPs. Consequently, the formation of 55S complexes containing these five snRNPs was not sufficient for the catalysis of the first step of splicing, indicating that some additional step(s) needs to occur subsequent to this binding. These results indicate that the 5' splice site, 3' and branch point of NS1 and mRNA were capable of interacting with the five snRNPs to form 55S complexes, but apparently some other sequence element(s) in NS1 mRNA blocked the resolution of the 55S complexes that leads to the catalysis of splicing. On the basis of our results, we suggest mechanisms by which the splicing of NS1 is controlled in infected cells.
Mol
Cell Biol 1989 Jan
PMID:A block in mammalian splicing occurring after formation of large complexes containing U1, U2, U4, U5, and U6 small nuclear ribonucleoproteins. 252 88
A synthetic peptide corresponding to sequence 138-164 of
influenza
hemagglutinin elicited in rabbits antibodies that recognized different parts of the peptide, namely the loop region (139-146) and the rest of the peptide, region 147-164. This was shown both by direct binding and by competitive-inhibition experiments. Individual antisera differed in their specificity. The contribution of the Asp residue at position 144 to the antigenic specificity was shown in various inhibition assays. These data are in accordance with the reported effect of the exchange Gly----Asp on the serological specificity of
influenza
virus.
Mol
Immunol 1985 Jan
PMID:Specificity and cross-reactivity of synthetic peptides derived from a major antigenic site of influenza hemagglutinin. 257 25
A number of peptides of the hemagglutinin (HA) of X-31
influenza
virus have been synthesised. The amino acid sequences of some of these peptides represent regions of HA which have been postulated [Wiley et al., Nature, Lond. 289, 373-378 (1981)] to form the antigenic sites of this molecule. Animals were immunized with free peptide or peptide conjugated to a carrier and the resulting antisera examined for their capacities to bind to homologous peptide, whole HA, reduced and alkylated HA, and intact virus. Not all peptides examined in this way were immunogenic. Only antibodies raised against the C-terminus of HA1 peptide displayed binding to virus. This antiserum bound to the intact HA but not to the reduced and alkylated form of the molecule. These results raise questions as to the feasibility of using synthetic peptides of the
influenza
HA in short linear sequences to elicit neutralising antibody.
Mol
Immunol 1985 Feb
PMID:Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites. 257 29
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>